Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

How 2026’s Philanthropic ETFs ASD & DUTY Invest

BY | ETF Database
6:48 am ET 06/30/26 | 20 VIEWS
The ETF ecosystem is always changing and growing. Thanks to the ETF’s flexibility, transparency, and tradability, it can help investors achieve plenty of bespoke goals. That even includes investing with an eye towards philanthropic causes as with philanthropic ETFs ASD and DUTY.Key Takeaways: Philanthropic ETFs like DUTY and ASD, which launched this year, look to advocate for important causes while delivering for clients. The ETFs join existing funds like FLDZ and PINK, which also help causes — veterans and first responders, and cancer research, respectively. The funds’ use of the ETF wrapper, more tax efficient than mutual funds, has helped them deliver these strategies. The U.S. Defense ETF (DUTY) donates 10% of its management fee revenue to U.S. veterans, while the Defiance Autism Impact ETF (ASD), which launched June 1, invests in firms focused on autism research and care.  See more: Inside ASD: The Story Behind the First Autism ETF DUTY charges a 45 basis point (bps) fee to track a proprietary index of pure-play U.S. stocks tied to defense. The fund’s investments shall derive at least 50% of revenue from military systems, defense tech, logistics and mission support, and cybersecurity infrastructure.  That market cap-weighted index includes names like Palantir PLTR, which has benefitted from big contracts with the Trump administration The firm then takes 10% of its fee revenue and donates it to charities to bolster its claim to a place among other philanthropic ETFs.  ASD, meanwhile, will donate 100% of its profits to autism charities for two years following its launch. The strategy tracks an equal-weighted index of firms in developed markets that support individuals on the autism spectrum. Specifically, that includes firms across biotech, pharmaceuticals, healthcare, behavioral services, diagnostics, education and assistive tech. The ETF charges a 79-bps fee. Those two philanthropic ETFs that launched this year join other funds with a philanthropic lean. The Simplify Healthcare ETF (PINK ) and the TrueShares RiverNorth Patriot ETF (FLDZ ) charge 51 and 70 bps, respectively.  PINK is a 100% pro bono fund where net profits are donated to the Susan G. Komen foundation. The ETF actively invests in 80 to 100 health care stocks, ranging across biotech, gene therapy, medtech, and more. It has returned 18% over the last three months.  FLDZ, meanwhile, donates the majority of advisory fees and all profits generated by management to Folds of Honor, a non-profit providing educational scholarships to spouses and children of fallen or disabled military service members and first responders.  Together, those four philanthropic ETFs embrace the ETF’s flexibility and offer some great tools for investors to act in the world around them. From veterans and their families, to cancer and autism research, the causes these ETFs support may intrigue. For more news, information, and analysis, visit the Thematic Investing Content Hub. VettaFi LLC (“VettaFi”) is the index provider for ASD, for which it receives an index licensing fee. However, ASD is not issued, sponsored, endorsed, or sold by VettaFi, and VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of ASD.

More Commentary

Don’t Ignore the Potential of EM Bonds
BY | ETF Database
12:28 pm ET 06/30/26 | 8 VIEWS
Gold's Midyear Check-In: Debasement & Banks Remain Key
BY | ETF Database
2:29 pm ET 06/30/26 | 6 VIEWS
VIDEO: ETF of the Week: TVAL
BY | ETF Database
8:18 am ET 06/30/26 | 16 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.